Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review

BackgroundProstate-specific membrane antigen (PSMA) ligand PET/CT has significantly improved prostate cancer (PCa) imaging. However, in patients with poorly differentiated PCa or neuroendocrine transdifferentiation, [18F]fluorodeoxyglucose ([18F]FDG) PET/CT may provide additional diagnostic informat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cesare Michele Iacovitti, Marco Cuzzocrea, Alessio Rizzo, Matteo Bauckneht, Roberto C. Delgado Bolton, Gaetano Paone, Giorgio Treglia
Natura: Articolo
Lingua:inglese
Pubblicazione: Frontiers Media S.A. 2025-07-01
Serie:Frontiers in Medicine
Soggetti:
prostate cancer
PSMA
[18F]FDG
PET/CT
dual-tracer
hybrid imaging
Accesso online:https://www.frontiersin.org/articles/10.3389/fmed.2025.1607227/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Entra per informazioni su prenotazioni e richieste

Accesso online

https://www.frontiersin.org/articles/10.3389/fmed.2025.1607227/full

Documenti analoghi